Skip to content

The Living With a Long-Term Condition Study

Testing the Reliability and Validity of a New Measure for Illness-related Distress.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06072287
Acronym
LTC
Enrollment
600
Registered
2023-10-10
Start date
2023-06-28
Completion date
2024-01-10
Last updated
2023-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS, Arthritis, Asthma, Atrial Fibrillation, Cancer, Celiac Disease, Cerebrovascular Disorders, CKD, Copd, Cystic Fibrosis, Dementia, Diabetes, Eczema, Endometriosis, Epilepsy, Fibromyalgia, Heart Disease Chronic, Heart Diseases, Heart Failure, Hepatitis, Hidradenitis Suppurativa, High Blood Pressure, Hiv, Hypertension, IBD, IBS, Liver Diseases, Long COVID, Lupus Erythematosus, ME/CFS, Migraine, MND (Motor Neurone DIsease), Multiple Sclerosis, Neurological Disorder, Obesity, Osteoarthritis, Osteoporosis, Pain, Parkinson Disease, PCOS, POTS - Postural Orthostatic Tachycardia Syndrome, Rheumatoid Arthritis, Sickle Cell Disease, Spondylitis, Stroke

Keywords

mental health, depression, anxiety, chronic illness

Brief summary

Psychological distress (anxiety and depression) is common in and experienced differently by people living with long-term health conditions (LTCs). Being able to measure whether psychological distress is related to living with a LTC would allow researchers and clinicians to provide interventions specifically tailored to the challenges of living with a LTC and therefore provide the most appropriate support for these patients. Such a measure would also be useful in research to identify the presence of illness-related distress in different patient groups. This project will therefore create a new measure of illness-related distress that has applications for both research and clinical practice. This will involve the psychometric validation of the new illness-related distress measure to test how valid and reliable the measure is. The aim of the project is to provide initial validation of the Illness Related Distress Scale in a community sample, recruited through online platforms. The objective of the study is to gather initial validity and reliability data for the scale.

Detailed description

Background: see brief summary Project information: This study will be conducted online with participants from the UK. A series of standardised questionnaires will be used alongside the new questionnaire. Participants will be those who self-select to complete our survey by responding to advertisements. The invitation will include a link to the Qualtrics survey which includes the Participant Information Sheet, Eligibility Screening, Consent Form and Baseline Questionnaire. After completing eligibility screening and consent, participants will complete the baseline questionnaire which will include brief demographics (highest education level, long-term condition diagnoses, ethnicity age and gender), the new measure we are testing (the Illness Related Distress Scale), as well as the Patient Health Questionnaire (PHQ-8), Generalised Anxiety Disorder Scale (GAD-7), the Work and Social Adjustment Scale (WSAS). The baseline questionnaire will only include the Inflammatory Bowel Disease Distress Scale (IBD-DS) and Diabetes Distress Scale (DDS) if participants indicate that they have a diagnosis of the relevant condition. At 1 week follow-up, participants will be sent a Qualtrics link to complete our 1-week follow-up questionnaire which will include the new Illness-Related Distress Scale only. Participants: We are aiming to recruit 600-700 participants for the study.

Interventions

DIAGNOSTIC_TESTLiving with LTC Questionnaire

A questionnaire that will ask about demographic information, mental wellbeing and distress related to chronic illness.

Sponsors

King's College London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Over the age of 18 * Self-reported diagnosis of a Long-Term Condition * UK resident * Possession of an email address to enable all study procedures * Sufficient command of written and spoken English to understand study procedures

Exclusion criteria

* Under the age of 18 * Not living in the UK * No self-reported diagnosis of an LTC * Inability to complete questionnaires in English

Design outcomes

Primary

MeasureTime frameDescription
Illness-related distressWeek 0 and Week 131 item questionnaire developed by the research team designed to assess illness-related distresss.

Secondary

MeasureTime frameDescription
AnxietyWeek 0Seven-item Generalised Anxiety Disorder Scale (GAD-7). Minimum=0, maximum=21, with higher scores indicating greater anxiety.
Functional impairmentWeek 0Five-item Work and Social Adjustment Scale (WSAS). Minimum=0, maximum=50, with higher scores indicating greater functional impairment.
DepressionWeek 0Eight-item Patient Health Questionnaire - 8 (PHQ-8) Minimum=0, maximum=24, with higher scores indicating greater depression.
IBD Distress ScaleWeek 0IBD Distress Scale, a 28 item self-report IBD related distress questionnaire. Minimum=29, maximum=145, with higher scores indicating greater distress.
Cognitive and Behavioural Responses to SymptomsWeek 0Cognitive Behavioural Responses to Symptoms Questionnaire, 40 item self-report questionnaire consisting of seven subscales with items scored on a 5 point scale. Higher scores correspond with stronger presence of the specific cognitive/behavioural response. The seven subscales refer to 1) fear avoidance, 2) catastrophising, 3) damage beliefs, 4) embarassment avoidance 5) symptom focussing 6) all-or-nothing behaviour and 7) avoidance/resting behaviour.
Diabetes Related Distress ScaleWeek 0Diabetes Related Distress Scale (DDS-17), a 17 item self-report diabetes related distress questionnaire. Minimum=17, maximum=102, with higher scores indicating greater distress.

Countries

United Kingdom

Contacts

Primary ContactNatasha Seaton, MSc
LTC-study@kcl.ac.uk0207 188 1189
Backup ContactNatasha Seaton, MSc
natasha.seaton@kcl.ac.uk0207 188 1189

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026